Collaborative models in which pharmacists are responsible for buprenorphine induction and
ongoing management with methadone and buprenorphine have been shown to reduce …

Opioid use disorder (OUD) is a chronic relapsing condition characterized by problematic
opioid use causing significant impairment in daily life. Medication for opioid use disorder …

Background Adolescent opioid misuse has been recognized as a dire public health issue.
Despite efforts to address the opioid epidemic in the United States, opioid-related morbidity …

In the last decade, the US opioid overdose crisis has magnified, particularly since the
introduction of synthetic opioids, including fentanyl. Despite the benefits of medications for …

Access to new syringes can reduce the risk of HIV and hepatitis C transmission, skin and soft
tissue infections, and infectious endocarditis for people who inject drugs (PWID). Syringe …

Abstract Background West Virginia (WV) has the highest overdose mortality rate in the
United States and expanding naloxone access is crucial for reducing opioid overdose …

Background Amidst an unprecedented overdose epidemic, the opioid partial agonist
buprenorphine is a medication for opioid use disorder associated with reductions in …

Opioids refer to chemicals that agonize opioid receptors in the body resulting in analgesia
and sometimes, euphoria. Opiates include morphine and codeine; semi-synthetic opioids …

Objective This study aimed to explore and identify motivational factors and barriers for
pharmacy personnel participation in specific opioid mitigation programs, using the Theory of …

Methods We implemented the Opioid and Naloxone Education (ONE) program in North
Dakota to give community pharmacies and pharmacists training and tools to provide …